Piper Sandler lowered the firm’s price target on Fulgent Genetics (FLGT) to $22 from $26 following quarterly results. The firm keeps a Neutral rating on the shares.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FLGT: